Challenges of scientific collaboration during an outbreak: the recent experience with Zika in Brazil
Global research platforms receive €30M to combat Zika Oxford --21 October 2016, ISARIC members are part of two successful bids to the European Union’s Horizon 2020 Research and Innovation Programme that will set up multinational and multi-disciplinary research consortia to combat Zika virus (ZIKV) infection and build pandemic preparedness in Latin America and the Caribbean over the next 3 to 5 years, the European Commission announced today.
Video of Professor Peter Horby, the University of Oxford, on how he and his team set up clinical trials in the heart of the Ebola outbreak.
Whilst our understanding of drug resistant Plasmodium falciparum is quite well understood, the extent and nature of resistance in Plasmodium vivax parasites is for the most part unknown.
The ISARIC-WHO Clinical Characterisation Protocol for Severe Emerging Infection, with supporting documents. Under WHO ERB review.
Professor Peter Piot, LSHTM, talks about Ebola and implications for Africa and understanding future epidemics at the Martin School, University of Oxford, 16th October 2014.
Access the WHO/ISARIC Clinical Characterisation Protocol for Severe Emerging Infection (v7), which is currently being rolled out in the UK. Site files for other countries will be made available in due course.
You can download protocols from a variety of sites implementing the ISARIC-SARI-BSProtocol by selecting the document from the list on the right.
ISARIC/WHO BSP sampling plan and CRF adapted by the Singapore Severe Acute Respiratory Infection Study Group, available for download.
This is the ISARIC case-report form if you wish to use it for cases of human infection with the novel coronavirus (hCoV-EMC).
A bibliography for articles that may be of interest when treating patients diagnosed with novel coronavirus.
ISARIC - Inernational Severe Acute Respiratory and Emerging Infection Consortium broadcast a statement outlining proposals for a research agenda with regards to the novel coronavirus, through ProMED on December 8th. The statement includes a description of potential observatinal studies, RCTs, a sampling plan, and suggestions for possible interventions.
A sample plan for sample collection with regards to a potential novel coronavirus outbreak, developed by Kenneth Baillie and ISARIC's Working Group 3.